This summer has seen the arrival of three new members on the NJC editorial team:
• Eva Balentova (Deputy Editor)
• Cynthia Challencin (Publishing Assistant)
• Ling Peng (Assistant Editor)
Read short profiles of each below, and more details on the NJC CNRS website.
Dr Eva Balentova was recently recruited as the Deputy Editor of NJC, replacing Dr Marie Cote (now with RSC Publishing in Cambridge).
Eva carried out her Ph.D. research in organic chemistry at the University of Pavol Jozef Šafárik in Košice, a city in eastern Slovakia. These studies involved long-term stays at both Turku University (Finland) and Universidad del País Vasco (EHU) in Spain. Postdoctoral positions at EHU and in France (Nancy and Montpellier) followed.
Eva’s research background in organic and natural product synthesis, as well as medicinal, peptide and carbohydrate chemistry, will beautifully complement the scientific expertise already covered by the other NJC editors.
Joining Eva in the Montpellier office is Cynthia Challencin, who was born in the Haute Savoie region of France but left to grow up under the sun of Guadeloupe until she was 18.
Cynthia came back to her native land three years ago and is now a student in a Masters of Translation French-English-Italian program, after obtaining her Bachelor’s degree in foreign languages. In parallel to her studies, Cynthia will work part-time as a publishing assistant in the Montpellier office.
Dr Ling Peng, a CNRS research director at the Interdisciplinary Center on Nanoscience in Marseille, is the 3rd assistant editor to join the NJC team.
Originally from China, Ling did her Ph.D. studies at the Swiss Federal Institute of Technology in Zurich under the direction of Prof. Albert Eschenmoser, then joined the group of Prof. Maurice Goeldner at Louis Pasteur University in Strasbourg in France.
A CNRS researcher since 1997, Ling’s principal research interests are the development of multi-functional dendrimers as nanovectors for nucleic acid and drug delivery, and as small molecular probes for exploring biological process and drug discovery.
We welcome all three to the NJC team!
